Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Nucleoside Analogues. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthetic route for Emtricitabine using dihaloacetic acid ensures high purity and cost efficiency. Ideal for pharmaceutical supply chain optimization.
Patent CN107501266A details a novel Pd-catalyzed asymmetric allylic amination route for high-purity nucleoside intermediates, offering significant supply chain and cost advantages.